Diabetes drug that became a viral hit for weight loss shows benefits for obese teens

Embargoed until: Publicly released: 2022-11-03 07:45

International

Credit: UConn Rudd Center for Food Policy and Health.

The diabetes drug Ozempic (semaglutide), which became a viral hit for weight loss thanks to TikTok, has now been shown to be effective at reducing Body Mass Index (BMI) in obese teens. The small study of around 200 teens found that after just over a year, around 73% of people taking the drug had weight loss of 5% or more, as compared with just 18% taking a placebo.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Paracelsus Medical University, Austria

Funder: Funded by Novo Nordisk; STEP TEENS ClinicalTrials. gov number, NCT04102189

Media Contact/s

Contact details are only visible to registered journalists.